Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Functional morphology of thymus is studied in 10 autopsy cases of
systemic lupus erythematosus
(
SLE
) in patients of 8 to 30 years, treated with high doses of glucocorticosteroids (GCS) alone or in combination with tactivin or without immunomodulating therapy. Manifestations of
SLE
are interstitial
thymitis
and pronounced thymus parenchyma atrophy which is present regardless of therapy. In the absence of the therapy with high doses of GCS, increase of perivascular spaces of thymus lobules with the appearance in these spaces of lymphoid follicles results in the false increase of the thymus volume and weight simulating its hyperplasia. GCS therapy enhances parenchymal atrophy and decreases the size of perivascular spaces. The use of tactivin against this background results in some normalization of thymic structure enhancing the lymphocyte proliferative activity. Effect of tactivin is masked by a more powerful GCS therapy.
...
PMID:[The functional morphology of the thymus in systemic lupus erythematosus and its characteristics during immunodepressive and immunostimulating therapies]. 235 97